Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice.

Dorothea Rat , Ulrich Schmitt , Frank Tippmann , Ilse Dewachter , Clara Theunis , Ewa Wieczerzak , Rolf Postina , Fred van Leuven , Falk Fahrenholz , Elżbieta Kojro

Abstract

n/a
Author Dorothea Rat
Dorothea Rat,,
-
, Ulrich Schmitt
Ulrich Schmitt,,
-
, Frank Tippmann
Frank Tippmann,,
-
, Ilse Dewachter
Ilse Dewachter,,
-
, Clara Theunis
Clara Theunis,,
-
, Ewa Wieczerzak (FCh / DBCh / LMCh)
Ewa Wieczerzak,,
- Laboratory of Medical Chemistry
, Rolf Postina
Rolf Postina,,
-
, Fred van Leuven
Fred van Leuven,,
-
, Falk Fahrenholz
Falk Fahrenholz,,
-
, Elżbieta Kojro
Elżbieta Kojro,,
-
Journal seriesFASEB Journal, ISSN 0892-6638, (A 35 pkt)
Issue year2011
Vol25
No9
Pages3208-3218
Keywords in EnglishPAC1 receptor, G-protein-coupled receptor, neuroprotection, nasal delivery
DOIDOI:10.1096/fj.10-180133
URL http://www.fasebj.org/content/25/9/3208.full.pdf+html
Languageen angielski
Score (nominal)40
Publication indicators WoS Impact Factor: 2011 = 5.712 (2) - 2011=6.34 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back